This case underscores the importance of recognizing the broader immunologic and rheumatologic spectrum of G-CSF-induced toxicity—including vasculitis, autoimmune manifestations, and delayed-onset myopathy—even in previously healthy donors. This evidence concerns the gene CSF3 and vasculitis.